Skip to main content
AT

ArteryFlow Technology

ArteryFlow develops a smart medical diagnostic system that utilizes deep learning algorithms and computational simulation techniques to provide precise and personalized assessments for cardiovascular and cerebrovascular diseases. Their technology enables non-invasive functional evaluations of myocardial ischemia and aneurysm rupture risk, improving diagnostic accuracy and treatment outcomes in clinical settings.

Founded 201719300+ followers
Updated 4 months ago

Funding

Funding not disclosed

Funding rounds are not available yet.

Founders

Product

Problem

Diagnosing cardiovascular and cerebrovascular diseases often relies on invasive procedures or provides limited functional information, hindering precise and personalized treatment plans. Traditional methods may not accurately assess the functional impact of arterial stenosis or aneurysm rupture risk.

Solution

ArteryFlow offers a non-invasive medical diagnostic platform that leverages computational fluid dynamics and deep learning to provide personalized assessments of cardiovascular and cerebrovascular health. By analyzing standard medical images (CTA, DSA, MRA, CT perfusion), the system simulates blood flow and quantifies functional parameters such as fractional flow reserve (FFR) and rupture risk. This enables clinicians to evaluate the hemodynamic significance of lesions, predict aneurysm stability, and optimize treatment strategies without the need for invasive guide wires or pressure sensors. The platform integrates into existing clinical workflows, delivering actionable insights through intuitive visualizations and quantitative reports.

Target Audience

The primary target audience includes cardiologists, interventional radiologists, neurologists, and neurosurgeons seeking advanced diagnostic tools for assessing cardiovascular and cerebrovascular diseases.

Features

  • AccuFFRct: Non-invasive FFR assessment from coronary CTA images, quantifying myocardial ischemia.
  • AccuFFRangio: Angiography-based FFR calculation without guide wires.
  • AccuIMR: Assesses coronary microcirculation to diagnose microvascular dysfunction.
  • AneuFlow: Determines the rupture risk of cerebral aneurysms from DSA, CTA, or MRA images.
  • AneuGuide: Provides guidance for selecting appropriate intracranial stent sizes during aneurysm coiling procedures.
  • AccuCTP: Quantifies cerebral infarction extent from CT perfusion imaging to optimize stroke treatment.
  • AccuICAS: Assesses intracranial arterial stenosis from DSA or CTA images.
  • AI-powered image processing and computational fluid dynamics algorithms for accurate and rapid analysis.
  • Cloud-based platform with secure data storage and access.
This profile is AI-generated and may contain inaccuracies.